DK2285411T3 - Nikotintabletsammensætninger - Google Patents

Nikotintabletsammensætninger

Info

Publication number: DK2285411T3
Authority: DK; Denmark
Prior art keywords: tablet compositions; nicotine tablet; nicotine; compositions; tablet
Prior art date: 2008-05-01

Application number

DK09739749.1T

Other languages

English (en)

Inventor

Li-Lan Chen

Original Assignee

Glaxosmithkline Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-05-01

Filing date

2009-04-30

Publication date

2017-01-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41255405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2285411(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-04-30 Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc

2017-01-02 Application granted granted Critical

2017-01-02 Publication of DK2285411T3 publication Critical patent/DK2285411T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Addiction (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Zoology (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Manufacture Of Tobacco Products (AREA)

DK09739749.1T 2008-05-01 2009-04-30 Nikotintabletsammensætninger DK2285411T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4951508P	2008-05-01	2008-05-01
PCT/US2009/042190 WO2009134947A1 (en)	2008-05-01	2009-04-30	Nicotine lozenge compositions

Publications (1)

Publication Number	Publication Date
DK2285411T3 true DK2285411T3 (da)	2017-01-02

Family

ID=41255405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09739749.1T DK2285411T3 (da)	2008-05-01	2009-04-30	Nikotintabletsammensætninger

Country Status (18)

Country	Link
US (3)	US8501164B2 (da)
EP (1)	EP2285411B1 (da)
JP (2)	JP5893405B2 (da)
CN (1)	CN102076362B (da)
AR (1)	AR071420A1 (da)
AU (1)	AU2009243065B2 (da)
BR (1)	BRPI0911847B8 (da)
CA (1)	CA2723011A1 (da)
CL (1)	CL2009001025A1 (da)
DK (1)	DK2285411T3 (da)
ES (1)	ES2605244T3 (da)
HU (1)	HUE031175T2 (da)
MX (1)	MX2010011929A (da)
MY (1)	MY164646A (da)
PL (1)	PL2285411T3 (da)
PT (1)	PT2285411T (da)
RU (1)	RU2458692C2 (da)
WO (1)	WO2009134947A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2536409A4 (en)	2010-02-18	2013-07-17	Jatin Vasant Thakkar	NICOTINE-CONTAINING SOFT GELATINETABLETTEN
UA112974C2 (uk)	2010-09-16	2016-11-25	Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид	Нікотиновмісна композиція (варіанти)
US9084439B2 (en)	2011-09-22	2015-07-21	R.J. Reynolds Tobacco Company	Translucent smokeless tobacco product
US9629392B2 (en)	2011-09-22	2017-04-25	R.J. Reynolds Tobacco Company	Translucent smokeless tobacco product
US9474303B2 (en)	2011-09-22	2016-10-25	R.J. Reynolds Tobacco Company	Translucent smokeless tobacco product
US20130078307A1 (en)	2011-09-22	2013-03-28	Niconovum Usa, Inc.	Nicotine-containing pharmaceutical composition
US9763928B2 (en)	2012-02-10	2017-09-19	Niconovum Usa, Inc.	Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en)	2012-04-17	2015-06-02	R.J. Reynolds Tobacco Company	Remelted ingestible products
AR096223A1 (es) *	2013-05-10	2015-12-16	Glaxosmithkline Llc	Pastilla de nicotina para administración oral
US10244786B2 (en)	2013-10-03	2019-04-02	Altria Client Services Llc	Tobacco lozenge
US9999243B2 (en)	2013-10-03	2018-06-19	Altria Client Services Llc	Exhausted tobacco lozenge
US11779045B2 (en)	2013-10-03	2023-10-10	Altria Client Services Llc	Dissolvable-chewable exhausted-tobacco tablet
US9351936B2 (en)	2013-10-03	2016-05-31	Altria Client Services Llc	Nicotine lozenge
US10105320B2 (en)	2013-10-03	2018-10-23	Altria Client Services	Soluble fiber lozenge
EP3052081B1 (en)	2013-10-03	2020-12-09	Altria Client Services LLC	Lozenge
US12274276B2 (en)	2013-10-03	2025-04-15	Altria Client Services Llc	Dissolvable-chewable tablet
US20170172995A1 (en) *	2015-09-08	2017-06-22	Venkateswara Rao Repaka	Pharmaceutical compositions of Nicotine and process for preparation thereof
ES2814296T3 (es)	2016-04-21	2021-03-26	Fertin Pharma As	Producto para administración de nicotina, usos relacionados y formas de dosificación oral y métodos de producción
WO2019110072A1 (en)	2017-12-08	2019-06-13	Fertin Pharma A/S	Nicotine tablet
EP3720497A1 (en) *	2017-12-08	2020-10-14	Fertin Pharma A/S	High nicotine concentration
ES3015556T3 (en) *	2017-12-08	2025-05-06	Fertin Pharma As	Solid oral nicotine formulation
CA3085066C (en) *	2017-12-08	2024-01-09	Fertin Pharma A/S	Formulations providing high nicotine concentrations
CA3040547C (en)	2019-04-17	2021-12-07	Medcan Pharma A/S	Cannabinoid lozenge formulation
US11759419B2 (en) *	2019-10-11	2023-09-19	Fertin Pharma A/S	Compressed nicotine lozenge
US12702643B2 (en)	2019-10-11	2026-08-11	Fertin Pharma A/S	Ion-exchange composition with water-soluble mucoadhesive polymers
US11000540B1 (en) *	2019-11-22	2021-05-11	Al Siamon	Treatment for reducing adverse events including chemotherapy discomfort and other conditions
US11793230B2 (en)	2019-12-09	2023-10-24	Nicoventures Trading Limited	Oral products with improved binding of active ingredients
CN115003281A (zh) *	2020-01-15	2022-09-02	麦克内尔股份公司	锭剂
USD1081739S1 (en)	2021-04-06	2025-07-01	Altria Client Services Llc	Die for gum forming
US20220387328A1 (en) *	2021-06-04	2022-12-08	Glaxosmithkline Consumer Healthcare Holdings (Us) Llc	Dosage form for nicotine replacement therapy
EP4408184A1 (en) *	2021-09-30	2024-08-07	Nicoventures Trading Limited	Oral gum composition
US12295412B2 (en)	2022-01-28	2025-05-13	Altria Client Services Llc	Oral pouch product
CN115813007B (zh) *	2022-12-22	2025-02-14	东莞市吉纯生物技术有限公司	尼古丁口含制品及制备方法和碱性电解水的制备方法
DK182273B1 (en) *	2023-07-07	2026-01-30	Fertin Pharma As	Dissolvable orally adhering nicotine tablet
DK182278B1 (en) *	2023-07-07	2026-02-04	Fertin Pharma As	Dissolvable orally adhering tablet

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4863737A (en)	1985-05-01	1989-09-05	University Of Utah	Compositions and methods of manufacture of compressed powder medicaments
GB8615676D0 (en)	1986-06-26	1986-07-30	Stoppers Co Ltd	Nicotine containing lozenge
US5135753A (en) *	1991-03-12	1992-08-04	Pharmetrix Corporation	Method and therapeutic system for smoking cessation
US5549906A (en)	1993-07-26	1996-08-27	Pharmacia Ab	Nicotine lozenge and therapeutic method for smoking cessation
TR199802305T2 (xx)	1996-05-13	2002-06-21	Norvartis Consumer Health S.A.	Yanaktan uygulama y�ntemi.
ATE447398T1 (de)	1998-12-18	2009-11-15	Alza Corp	Durchsichtige transdermale nicotinabgabevorrichtungen
FR2792200B3 (fr) *	1999-04-16	2001-06-08	Unicliffe Ltd	Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
WO2002085119A1 (en)	2001-04-20	2002-10-31	Lavipharm Laboratories Inc.	Intraoral delivery of nicotine for smoking cessation
SE0102197D0 (sv)	2001-06-20	2001-06-20	Pharmacia Ab	New product and use and manufacture thereof
MXPA04006163A (es)	2001-12-20	2004-11-01	Pharmacia Corp	Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
US7767698B2 (en)	2002-06-03	2010-08-03	Mcneil Ab	Formulation and use thereof
US20040052851A1 (en) *	2002-09-16	2004-03-18	Graff Allan H.	Modified release oral dosage form
EP1578422B1 (en) *	2002-12-20	2007-04-11	NicoNovum AB	A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
US20040182403A1 (en)	2003-02-28	2004-09-23	Sven-Borje Andersson	Container comprising nicotine and the use and manufacture thereof
GB0320854D0 (en)	2003-09-05	2003-10-08	Arrow No 7 Ltd	Buccal drug delivery
DK1663168T3 (da)	2003-09-08	2009-06-08	Mcneil Ab	Nikotinformuleringer og anvendelse deraf
US20050123502A1 (en) *	2003-10-07	2005-06-09	Chan Shing Y.	Nicotine containing oral compositions
US8323683B2 (en)	2005-05-18	2012-12-04	Mcneil-Ppc, Inc.	Flavoring of drug-containing chewing gums
AU2007224586A1 (en)	2006-03-16	2007-09-20	Niconovum Ab	Stable lozenge compositions providing rapid release of nicotine
US20070269386A1 (en)	2006-05-16	2007-11-22	Per Steen	New product and use and manufacture thereof
US20070269492A1 (en)	2006-05-16	2007-11-22	Per Steen	New product and use and manufacture thereof
US20080287507A1 (en)	2007-05-16	2008-11-20	John Hedenstrom	Nicotine containing toiletry waters
US20080286340A1 (en)	2007-05-16	2008-11-20	Sven-Borje Andersson	Buffered nicotine containing products
US20080286341A1 (en)	2007-05-16	2008-11-20	Sven-Borje Andersson	Buffered coated nicotine containing products
US20090004248A1 (en)	2007-06-29	2009-01-01	Frank Bunick	Dual portion dosage lozenge form
US20090164008A1 (en) *	2007-12-21	2009-06-25	Xin Hong	Lens surface with combined diffractive, toric, and aspheric components
PT2361081T (pt)	2008-10-14	2016-09-05	Mcneil Ab	Forma de dosagem intra-oral multiporção e seu uso
EP2233134A1 (en)	2009-03-27	2010-09-29	McNeil AB	Multi-portion intra-oral dosage form with organoleptic properties
US8784781B2 (en)	2009-09-24	2014-07-22	Mcneil-Ppc, Inc.	Manufacture of chewing gum product with radiofrequency

2009
- 2009-04-29 CL CL2009001025A patent/CL2009001025A1/es unknown
- 2009-04-29 AR ARP090101535 patent/AR071420A1/es not_active Application Discontinuation
- 2009-04-30 PT PT97397491T patent/PT2285411T/pt unknown
- 2009-04-30 DK DK09739749.1T patent/DK2285411T3/da active
- 2009-04-30 JP JP2011507628A patent/JP5893405B2/ja active Active
- 2009-04-30 EP EP09739749.1A patent/EP2285411B1/en active Active
- 2009-04-30 PL PL09739749T patent/PL2285411T3/pl unknown
- 2009-04-30 WO PCT/US2009/042190 patent/WO2009134947A1/en not_active Ceased
- 2009-04-30 ES ES09739749.1T patent/ES2605244T3/es active Active
- 2009-04-30 CN CN200980125040.6A patent/CN102076362B/zh active Active
- 2009-04-30 RU RU2010149050/15A patent/RU2458692C2/ru active
- 2009-04-30 MY MYPI2010005122A patent/MY164646A/en unknown
- 2009-04-30 HU HUE09739749A patent/HUE031175T2/en unknown
- 2009-04-30 AU AU2009243065A patent/AU2009243065B2/en active Active
- 2009-04-30 US US12/990,049 patent/US8501164B2/en active Active
- 2009-04-30 BR BRPI0911847A patent/BRPI0911847B8/pt active IP Right Grant
- 2009-04-30 MX MX2010011929A patent/MX2010011929A/es active IP Right Grant
- 2009-04-30 CA CA 2723011 patent/CA2723011A1/en not_active Abandoned
2013
- 2013-06-26 US US13/927,163 patent/US8940772B2/en active Active
2014
- 2014-12-17 US US14/572,953 patent/US20150105431A1/en not_active Abandoned
2015
- 2015-07-27 JP JP2015147991A patent/JP6159761B2/ja active Active

Also Published As

Publication number	Publication date
BRPI0911847A2 (pt)	2015-10-06
AU2009243065B2 (en)	2013-05-23
EP2285411B1 (en)	2016-09-21
CN102076362B (zh)	2015-01-21
JP6159761B2 (ja)	2017-07-05
US8940772B2 (en)	2015-01-27
BRPI0911847B8 (pt)	2021-05-25
EP2285411A4 (en)	2011-05-18
US20110110880A1 (en)	2011-05-12
RU2458692C2 (ru)	2012-08-20
PL2285411T3 (pl)	2017-07-31
WO2009134947A1 (en)	2009-11-05
US8501164B2 (en)	2013-08-06
CN102076362A (zh)	2011-05-25
RU2010149050A (ru)	2012-06-10
HUE031175T2 (en)	2017-06-28
JP2015232012A (ja)	2015-12-24
CL2009001025A1 (es)	2010-09-24
HK1153146A1 (zh)	2012-03-23
AR071420A1 (es)	2010-06-16
US20130289079A1 (en)	2013-10-31
EP2285411A1 (en)	2011-02-23
PT2285411T (pt)	2016-11-25
US20150105431A1 (en)	2015-04-16
AU2009243065A1 (en)	2009-11-05
BRPI0911847A8 (pt)	2018-03-06
BRPI0911847B1 (pt)	2021-04-13
JP5893405B2 (ja)	2016-03-23
MX2010011929A (es)	2010-11-30
MY164646A (en)	2018-01-30
CA2723011A1 (en)	2009-11-05
ES2605244T3 (es)	2017-03-13
JP2011519862A (ja)	2011-07-14

Publication	Publication Date	Title
EP2285411A4 (en)	2011-05-18	NICOTINE COMPOSITION IN THE FORM OF AIRBOX
LTC2140867I2 (lt)	2018-11-12	Farmacinė kompozicija
FI20085052L (fi)	2009-07-23	Tupakkatuote
DK2634232T3 (da)	2022-06-07	Sammensætninger
DK3097925T3 (da)	2019-08-05	Farmaceutisk sammensætning
BRPI0906749A2 (pt)	2015-07-07	Composição
BRPI0913808A2 (pt)	2017-06-20	composição
BRPI1004940A2 (pt)	2018-06-19	composição farmacêutica
DK3492069T3 (da)	2022-03-14	Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI1012539A2 (pt)	2016-03-29	composições farmacêuticas
IT1392101B1 (it)	2012-02-09	Composizione comprendente isoflavoni
BRPI0917231A2 (pt)	2015-11-10	composição
BRPI1015939A2 (pt)	2016-09-27	composição farmacêutica
DE602008003972D1 (de)	2011-01-27	Sitzrücklehnungsmechanismus
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
DK3300729T3 (da)	2020-01-20	Terapeutiske sammensætninger indeholdende macitentan
IT1394400B1 (it)	2012-06-15	Composizioni farmaceutiche
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
BR112012003149A2 (pt)	2016-03-01	composição farmacêutica
BR112012001340A2 (pt)	2016-03-15	composições farmacêuticas